LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about CytomX Therapeutics

Similar companies to CytomX Therapeutics

CytomX Therapeutics Tech Stack

CytomX Therapeutics uses 8 technology products and services including SAS/STAT, Google Analytics, Cookiebot, and more. Explore CytomX Therapeutics's tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • Google Analytics
    Analytics
  • Cookiebot
    Cookie Compliance
  • git
    Development
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Backbone.js
    Javascript Frameworks
  • VMware
    Virtualisation Software
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

CytomX Therapeutics's Email Address Formats

CytomX Therapeutics uses at least 1 format(s):
CytomX Therapeutics Email FormatsExamplePercentage
FLast@cytomx.comJDoe@cytomx.com
92%
FiLast@cytomx.comJoDoe@cytomx.com
4%
First@cytomx.comJohn@cytomx.com
2%
First.Last@cytomx.comJohn.Doe@cytomx.com
2%

Frequently Asked Questions

Where is CytomX Therapeutics's headquarters located?

Minus sign iconPlus sign icon
CytomX Therapeutics's main headquarters is located at 151 Oyster Point Blvd South San Francisco, CA 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is CytomX Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact CytomX Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CytomX Therapeutics's stock symbol?

Minus sign iconPlus sign icon
CytomX Therapeutics is a publicly traded company; the company's stock symbol is CTMX.

What is CytomX Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
CytomX Therapeutics's official website is cytomx.com and has social profiles on LinkedIn.

How much revenue does CytomX Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, CytomX Therapeutics's annual revenue reached $35M.

What is CytomX Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
CytomX Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CytomX Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, CytomX Therapeutics has approximately 155 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Business Officer And Head Of Strategy: J. L.Chief Scientific Officer And Head, Research And Early Development: M. K.Chief Business Officer: N. G.. Explore CytomX Therapeutics's employee directory with LeadIQ.

What industry does CytomX Therapeutics belong to?

Minus sign iconPlus sign icon
CytomX Therapeutics operates in the Biotechnology Research industry.

What technology does CytomX Therapeutics use?

Minus sign iconPlus sign icon
CytomX Therapeutics's tech stack includes SAS/STATGoogle AnalyticsCookiebotgitTwitter Emoji (Twemoji)Backbone.jsVMwareAcquia Cloud Site Factory.

What is CytomX Therapeutics's email format?

Minus sign iconPlus sign icon
CytomX Therapeutics's email format typically follows the pattern of . Find more CytomX Therapeutics email formats with LeadIQ.

How much funding has CytomX Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, CytomX Therapeutics has raised $94M in funding. The last funding round occurred on Jan 21, 2021 for $94M.
CytomX Therapeutics

CytomX Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

CytomX Therapeutics, Inc. is committed to changing the treatment of cancer with our novel Probody® therapeutic platform. We have a broad pipeline comprised of five clinical-stage programs, with even more in development. 

Our commitment to transforming lives with safer, more effective therapies is driven by our curiosity and passion for innovation, and our belief that by acting with integrity in an honest, respectful, ethical manner, we have the power to change lives. Our workplace embodies collaboration, open communication, celebrating our successes and holding each other to the highest possible standards. 

CytomX embraces diversity and seeks to enhance and maintain our culture of equity and inclusion which encourages individuals to be themselves, feel involved, respected and connected.

We at CytomX believe that we benefit from each other’s ideas and experiences. We accept our differences and learn from one another, improve together, and embrace change to achieve our corporate and individual objectives. This belief applies to how we work together at CytomX, how we work with others outside CytomX, how we represent CytomX in our communities, and how we endeavor to bring our scientific innovations to a diverse patient population.

CytomX acknowledges the importance of diversity, equity and inclusion initiatives and that they require an evolving and ongoing commitment. CytomX is an equal opportunity employer and does not discriminate against any individual or potential candidate because of race, color, religion, sex, national origin, sexual preference or any other legally protected category.

CytomX is located in South San Francisco, California, the birthplace of biotechnology. Learn more about us and how we are advancing science to treat cancer differently at www.cytomX.com.

Section iconCompany Overview

Headquarters
151 Oyster Point Blvd South San Francisco, CA 94080 US
Phone number
Website
cytomx.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CTMX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $94M

    CytomX Therapeutics has raised a total of $94M of funding over 8 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $94M.

  • $10M$50M

    CytomX Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $94M

    CytomX Therapeutics has raised a total of $94M of funding over 8 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $94M.

  • $10M$50M

    CytomX Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.